Vladimir Valica

Vladimir Valica

Auto-generated profile, based on publicly available information

Vladimir Valica

Scientific Center for Drug Research “Nicolae Testemitanu” State University of Medicine and Pharmacy 165 bd. Stefan Cel Mare si Sfant Chisinau MD-2004 Moldova

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2024 in Chemistry & Biodiversity
Verified
Journal Article
Open access
NSNatalia Stepanovna Sucman
Natalia Stepanovna Sucman
ESEugenia Stingaci
Eugenia Stingaci
LLLucian Lupascu
Lucian Lupascu
ASAnastasia Smetanscaia
Anastasia Smetanscaia
VVVladimir Valica
Vladimir Valica
FMFliur Macaev
Fliur Macaev
New 1H‐1,2,4‐triazolyl derivatives were synthesized, and six of them were selected based on docking prediction for the investigation of their antimicrobial activity against five bacterial and eight fungal strains. All compounds demonstrated antibacterial activity with MIC lower than that of the ampicillin and chloramphenicol. In general, the most sensitive bacteria appeared to be P. fluorescens, while the plant pathogen X. campestris was the most resistant. The antifungal activity of the compounds was much better than the antibacterial activity. All compounds were more potent (6 to 45 times) than reference drugs ketoconazole and bifonazole with the best activity achieved by compound 4 a. A. versicolor, A. ochraceus, A.niger, and T.viride showed the highest sensitivity to compound 4 b, while, T. viride, P. funiculosum, and P.ochrochloron showed good sensitivity to compound 4 a. Molecular docking studies suggest that the probable mechanism of antibacterial activity involves the inhibition of the MurB enzyme of E. coli, while CYP51 of C. albicans appears to be involved in the mechanism of antifungal activity. It is worth mentioning that none of the tested compounds violated Lipinski's rule of five.

1 October 2021 in The Moldovan Medical Journal
Verified
Journal Article
Closed access
Livia UncuLivia Uncu
Livia Uncu
VEVladilena Evtodienco
Vladilena Evtodienco
EMEcaterina Mazur
Ecaterina Mazur
EDElena Donici
Elena Donici
VVVladimir Valica
Vladimir Valica
Background: UV-Vis spectrophotometry remains the most accessible spectral method with a high degree of sensitivity and information. The advantage of the method consists in its universality, the ability to combine with other methods, the minimum error, as well as its economic efficiency. The objective of this study was the determination of some validation parameters for the spectrophotometric method of dosing piracetam and nicergoline in combined capsules. Material and methods: Agilent 8453 UV-Vis spectrophotometer, reference standards of piracetam and nicergoline, 0.1 M HCl methanolic solution. Validation of the spectrophotometric method according to the requirements of the ICH guide “Q2R1: For analytical procedures and validation”. Results: Linearity was investigated on concentration ranges 5-40 µg / mL. The regression (R2 ) values were 0.9998 for nicergoline and 0.998 for piracetam, respectively. The limit of detection was 1.737 µg / mL for nicergoline and 0.369 µg / mL for piracetam. Quantification limit values were also calculated as 5.265 and 1.118 µg / mL for nicergoline and piracetam, accordingly. The results obtained showed that the developed spectrophotometric method is accurate, precise and robust, because the value of the relative standard deviation was less than 1.0%. Conclusions: The developed spectrophotometric method showed specificity, linearity, accuracy, precision and robustness, and can be applied on the concentration range between 80-120% of the nominal value of the content of nicergoline and piracetam in the preparation.

1 February 2026
Verified
Conference Paper
Closed access
PDF file
EGElena Gorincioi
Elena Gorincioi
TSTatiana Stefanet
Tatiana Stefanet
ESEugenia Stingaci
Eugenia Stingaci
VVVladimir Valica
Vladimir Valica
FMFliur Macaev
Fliur Macaev
The current communication reports on the use of Nuclear Magnetic Resonance (NMR) Spectroscopy for the NMR characterization of 1-(2-oxopropyl)spiro[[1,3]indoline-3,2’- [1,3]dioxolan-2-one, for which anxyolitic and antidepressant effects have been found in preliminary tests. The combination of 1D and 2D homo- and heterocorrelation 1H/13C NMR experiments provided the unambiguous set of assignments. Studies regarding the properties of the title compound and its congeners are of great interest, as these compounds may be advanced for further biological testing and preclinical development, or used as possible lead compounds for the future design of Monoamine oxidase inhibitors.

1 October 2023
Verified
Conference Paper
Open access
PDF file
MCMaria Cojocaru-Toma
Maria Cojocaru-Toma
VVVladimir Valica
Vladimir Valica
VGVladilena Gandacov
Vladilena Gandacov
EMEcaterina Mazur
Ecaterina Mazur
Livia UncuLivia Uncu
Livia Uncu
Agrimonia eupatoria L. (Rosaceae fam.) is widespread in temperate regions. In folk medicine, this species has been used for its astringent, analgesic and anti-inflammatory, as well as in gastrointestinal disorders. As these biological properties have been linked to its phenolic composition, this plant species could be an interesting source of bioactive compounds with therapeutic potential [1]. For the evaluation of chemical compounds in A. eupatoria extract, the aerial parts were harvested in the flowering period from the collection of the Scientific Practical Centre in the Field of Medicinal Plants of “Nicolae Testemițanu” State University of Medicine and Pharmacy. The dry extracts were concentrated using a rotary evaporator-Laborota 4011. The analysis was performed on Shimadzu LC-20AD chromatograph with SPD-20A UV detector [2], under the following conditions: stationary phase - Zorbax Exlipse Plus C18 (4.6x250 mm, 5 microns); 2 mobile phases: solvent mixture: methanol: water (40:60) with gradient elution and orthophosphoric acid 0.5%: acetonitrile (80:20) with isocratic elution mode; detection at wavelengths of 280, 325 and 360 nm. The solvent system that achieved optimal separation of the phenolic compounds was the mixture of 0.5% orthophosphoric acid:acetonitrile (80:20) at a wavelength of 325 nm. The extract of A. eupatoria was found to be richer in tannins (catechin-3.68%, epicatechin-2.59%); in flavonoids (rutin-1.71%, quercetin-0.199%, luteolin-0.184%, kaempferol-0.162%, apigenin-0.078%, with a lower content of hydroxycinnamic acids (chlorogenic, caffeic, cycoric and ellagic). The HPLC method with UV-VIS detection can be successfully used in the identification and quantitative determination of chemical compounds in Agrimonia eupatoria extracts for the development and standardization of new pharmaceutical forms.

1 November 2025
Verified
Journal Article
Closed access
MNMihaela Nartea
Mihaela Nartea
AOAngelica Ohindovschi
Angelica Ohindovschi
MSMaria Statnic
Maria Statnic
VVVladimir Valica
Vladimir Valica
TSTatiana Stefanet
Tatiana Stefanet
MCMaria Cojocaru-Toma
Maria Cojocaru-Toma
The carotenoid and chlorophyll pigments in plant tissues are valuable because they help protect the photosynthetic apparatus. Spectrophotometric chemical analysis of extracts from species of the genus Helichrysum (H. arenarium and H. italicum) shows the highest carotenoid levels in the flowers, followed by the aerial parts, leaves and stems: H. arenarii flores - 10.74 mg /% and H. italici flores - 4.41 mg /% in 96% ethanol. Regarding chlorophyll pigments, a higher content of chlorophyll b was determined in leaves (H. arenarium - 10.7 mg /ml and H. italicum - 4.41 mg /ml in 96% ethanol). At the same time, the acetone extraction method revealed a higher chlorophyll a content in the leaves of both species (H. arenarii folia -98,92 mg/ml and H. italici folia - 51,61 mg/ml). These results indicate that both the choice of solvent and the nature of the plant material strongly influence the carotenoid and chlorophyll content.

1 December 2021 in Public Health, Economy and Management in Medicine
Verified
Journal Article
Open access
CSCorina Scutari
Corina Scutari
LRLiliana Rusnac
Liliana Rusnac
VVVladimir Valica
Vladimir Valica
MTMihail Todiras
Mihail Todiras
RCRadu Cazacu
Radu Cazacu
In this article, an informative presentation was made about the development of biosimilar and biosimilar growth hormone in Europe and the Republic of Moldova following the selection and analysis of 37 bibliographic sources from the PubMed database and from specialized journals. Human growth hormone was approved by the EMA in 2006 as the world’s first biosimilar drug. Recombinant growth hormone therapy is currently approved for growth hormone deficiency, Turner syndrome, chronic kidney failure, in children/adolescents born young for gestational age and Prader-Willi syndrome. At the same time, biosimulation therapy is very expensive. In the Republic of Moldova but also in Eastern Europe, the accessibility of biological medicines is extremely low due to the lack of local or regional producers. Th e development of the biosimilar production branch, including the biosimilar growth hormone in the Republic of Moldova, will be an attractive and pharmacoeconomically advantageous option for the therapeutic arsenal.